We examined whether the synthesis of inter leukin-1 or tumor necrosis factor, two cytokines with po tent inflammatory activities, is influenced by dietary sup plementation with n -3 fatty acids.
P = 0.005). The production of IL-1 a and tumor necrosis factor responded in a similar manner. Twenty weeks after the end of supplementation, the production of IL-1 /3, IL-1 a, and tumor necrosis factor had returned to the presupple ment level. The decreased production of interleukin-1 and tumor necrosis factor was accompanied by a decreased ratio of arachidonic acid to eicosapentaenoic acid in the membrane phospholipids of mononuclear cells.
We conclude that the synthesis of IL-1/3, IL-1 a, and tu mor necrosis factor can be suppressed by dietary supple mentation with long-chain n -3 fatty acids. The reported antiinflammatory effect of these n -3 fatty acids may be mediated in part by their inhibitory effect on the production of interleukin-1 and tumor necrosis factor. (N Engl J Med 1989; 320:265-71.) unsaturated fatty acids in which the last double bond is located between the third and fourth carbon atom from the methyl end of the fatty acid chain. These fatty acids are scarce in a normal Western diet but make up an appreciable part of the fat intake in diets rich in cold-water fish and seal meat.'' Epidemiologic studies in populations of coastal Eskimo,10,1! Ja p a nese,1" and D u tc h 1 * subjects have shown that a high intake of n -3 fatty acids correlates with a low inci dence of cardiovascular and inflammatory diseases such as asthma and Type I diabetes mellitus. 11 The modification of the fatty acid composition of cell membranes and the formation of eicosanoids by di etary supplementation with n -3 fatty acids have sub sequently been shown in h u m a n beings. 14, 10 In healthy volunteerslb and in patients with asthma,17 n -3 dietary supplementation results in decreased neutrophil chemotaxis and inhibited generation of leukotriene B4 by neutrophils and monocytes. In clini cal studies, dietary supplementation with n -3 fatty acids has led to improvements in patients with rheu matoid arthritis18 and in patients with psoriasis.14 Prospective studies in animals fed n -3 fatty acids sup port these clinical observations.20 '23 Since interleukin-1 and tumor necrosis factor are the principal polypeptide mediators of inflammation, 266 THE NEW ENGLAND JOURNAL OF MEDICINE Feb. 2, 1989 reduced production of these cytokines may contribute to the amelioration of inflammatory symptoms in pa tients receiving n -3 supplementation. In this study we investigated the effects of dietary supplementa tion with n -3 fatty acids on the synthesis of the cyto kines interleukin-1 and tumor necrosis factor in nor mal subjects.
M e t h o d s

Subjects and Study Design
The study was approved by the Human Investigative Review Committee of the New England Medical Center Hospitals. Nine healthy male volunteers entered the study after giving informed consent (average age, 28 years; range, 21 to 39). The initial study group consisted of six volunteers, and a second group of three volunteers entered the study six months after tlu* first group. Roth groups were studied in the same fashion. Since the results were similar in the two groups, the data for the nine subjects are pooled in this report.
For six weeks, the subjects added 18 g of marine lipid concentrate (six capsules of MaxEPA three times per day, kindly provided by R.P. Scherer. Troy, Mich.) to their otherwise unchanged diets. By gas chromatography, the n -3 fatty acid content of I g of the lipid concentrate was shown to consist of 153 mg of eicosapentaenoic acid and 103 g of docosahexaenoic acid. The subjects were free of disease and refrained from taking any medications during the course of the study. Before supplementation, the subjects' mean caloric intake ranged from 2 0 0 0 to 3000 kcal per day. Six to 1 0 percent of the calories (mean, 28 g) were highly unsaturated fatty acids, but less than 1 percent were n -3 fatty acids. During supplemen tation, the intake of highlv unsaturated fattv acids increased from 28 to 34 g.
The production of interleukin-1 and tumor necrosis factor by stimulated-blood mononuclear cells in vitro was assessed during four phases of the study: before the start of n -3 supplementation, during the 6 th week of supplementation, and during the 1 0 th and 2 0 th weeks after the end of supplementation (the latter two phases being washout periods). To ascertain reproducibility, blood sam ples were obtained on three different days, two to three days apart, during each of the four phases of the study. The mean of these three replicate determinations was calculated and used for further analy sis. We were unable to make measurements during the 20th week of the washout period in one of the six subjects in the first group of volunteers.
During the first six weeks of the study, when the second group of volunteers was taking the supplement, we also studied a control group of four healthy male volunteers who did not receive the sup plement. In vitro production of interleukin-1 and of tumor necrosis factor was assessed twice, during week 1 and week 7. Blood sam pling was performed on two different days during the first and seventh week, and the mean was calculated.
Stimulation of Mononuclear Cells in Vitro
Venous blood was drawn into syringes pretreated with heparin (20 U per milliliter), and the mononuclear-cell fraction was ob tained by Ficoll-Hypaque centrifugation. At the same time a sam ple of blood was obtained without heparin in order to prepare heatinactivated (56°C, 40 minutes) serum. The mononuclear cells were washed twice in 0.15 M sodium chloride, slides were prepared by cytocentrifugation, and 1 0 0 cell-differential counts were performed in a blinded fashion on coded slides. RPMI-1640 culture medium (Whittaker M.A. Bioproducts, Walkersville, Md.), supplemented with 2 niM levo-glutamine, 1 0 0 U of penicillin per milliliter, and 1 0 0 /zg of streptomycin per milliliter, was subjected to ultrafiltra tion to remove endotoxins, as described elsewhere. 24 The mononu clear cells were suspended at a concentration of 5 X 1 0 *' cells per milliliter in R P M I medium with 2 percent heat-inactivated autolo gous serum, and 100 ¡± \ was divided into aliquots in 96-well flatbottomed microtiter plates. An equal volume of either serum-free R P M I or R P M I containing various stimulants was added. The cells were stimulated with endotoxin (lipopolysaccharide Escherichia coli 055:B5, Sigma, St. Louis) at I and 10 ng per milliliter, phyto hemagglutinin (Difco, Detroit) at 3 /xg per milliliter, or heatkilled Staphylococcus epidermidis, opsonized with 2.5 percent fresh autologous serum, at 20 bacteria per mononuclear cell. After incu bation for 24 hours at 37°C in 5 percent carbon dioxide, the supcrnatants were removed from some wells and frozen at -70°C for the determination of prostaglandin E. The microtiter plates were frozen until the end of the study. At that time all the plates for each donor were simultaneously thawed and exposed to two more freeze-thaw cycles to complete cell lysis. The contents of triplicate wells, consisting of cell lysates and supernatants, were pooled and refrozen for determinations of interleukin-1 and tumor necro sis factor.
Determinations of lnterleukin-1 and Tumor Necrosis Factor
The total synthesis of cytokines (i.e., cell-associated cytokines plus secreted cytokines) was determined by radioimmunoassays for two forms of human interleukin-1 (IL-l/3and IL-la) and for tumor necrosis factor. Details on the specificity and sensitivity of each radioimmunoassay have been reported elsewhere.2 >i/ Each radio immunoassay was specific for the respective cytokine. For a given stimulus, samples from all four study phases for each donor were assayed in a single radioimmunoassay for each cytokine.
Prostaglandin Determination
Prostaglandin E^ content in mononuclear-cell supernatants was determined by direct competitive radioimmunoassay. Anti-pros taglandin Ej serum, kindly provided by Dr. William Campbell (University of Texas Health Science Center at Dallas), has a cross reactivity of 14 percent with prostaglandin E| and of 2.7 percent with prostaglandin E.,a. Prostaglandin E_> standard was provided by Dr. John Pike (Upjohn, Kalamazoo, Mich.). ['H]Prostaglandin E_, was purchased from Amersham (Arlington Heights, 111.). The assay does not distinguish between prostaglandin E2 and prostaglandin E {. The assay sensitivity for prostaglandin E2 is 50 pg per milliliter.
Neutrophil Chemotaxis
Polymorphonuclear neutrophils were isolated from the pellet after Ficoll-Hypaque density-gradient centrifugation, and their chemotactic response to synthetic leukotriene B.} (Sigma) was assaved with use of blind well chambers, as described elsewhere.2,1 # I'he migration distance of polymorphonuclear neutrophils was measured with the leading-front method. Each condition (buffer alone or with leukotriene B., added at 10~!l, 10-H, 10-7, and 10~fl M) was assayed in triplicate. Polymorphonuclear neutrophils from healthy subjects not receiving n -3 fatty acid supplementation were assayed in parallel (same-day control). The results are expressed as percent increases over spontaneous migration in buffer.
Fatty Acid Analyses
For the measurement of plasma fatty acids, 18 ml of blood was drawn into EDTA-coatcd tubes and centrifuged for 20 minutes at 800Xg. The plasma was removed and frozen at -70°C1 until ana lyzed. Lipids were extracted and methylated, as described else where.
For the determination of the fatty acid composition of mononuclear cells, cells obtained on three different days during each of the four study phases were pooled, for a total of 4 .5 x 1 0 '' mononuclear cells per subject. The lysates of these cells were centri fuged at 1 0 0 ,0 0 0 Xg and extracted, and the phospholipids were puri fied and transmethylated as described elsewhere. 1 0 The fatty acid methyl esters were analyzed by gas-liquid chromatography on an HP-5980 gas chromatograph.2 9 , 3 0 The amounts of individual fatty acids were expressed as relative percentages, with total fatty acids set as 1 0 0 percent.
Statistical Analysis
The results are expressed as means ±SEM. Two-tailed Student's t-tests for paired samples were performed on a Clinfo software sys tem (Bolt, Beranek and Newman, Cambridge, Mass.) After Bonier-roni's adjustment for multiple t-tests in one group, P values less than 0.05 were considered to be significant.
R e s u l t s
Plasma and Mononuclear-Cell Lipids
The volunteers reported no untoward effects of in gesting the fish-oil concentrate. Compliance was con firmed by a significant increase in plasma levels of eicosapentaenoic acid, from 0.4±0.' 2 mg per deciliter at base line to 17.3±0.7 mg per deciliter during the sixth week of supplementation (P<0.001). Plas ma eicosapentaenoic acid was still slightly increased (1.1 ±0.3 mg per deciliter; P = 0.035) 10 weeks after cessation of the supplement and returned to the presupplementation level (0.6± 0.2 mg per deciliter) within 20 weeks after cessation of the supplement. Triglyceride levels were reduced from the presupple mentation level (1.03±0.02 mmol per liter [91 ±20 mg per deciliter]) to 0.66±0.12 mmol per liter (59± 1 1 mg per deciliter) after six weeks of n -3 supple mentation (P<0.040). They returned to the presup plementation levels at 10 weeks (1.09±0.23 mmol per liter [97±21 mg per deciliter]) and 20 weeks (1.04±0.14 mmol per liter [93± 13 mg per deciliter]) after cessation of the supplement. Cholesterol levels and leukocyte and platelet counts did not change significantly. These data confirm previous findings on the effects of similar doses of n -3 fat tv acids on plasma levels of fatty acids30 and on triglyceride levels. 31 The composition of mononuclear-cell phospholipid fatty acids was determined in the mononuclear-cell membranes of five randomly chosen volunteers during the four study phases ( Table 1) . After six weeks of n -3 fatty acid supplementation, there was a signifi cant increase in eicosapentaenoic acid, from 0.7 per cent before the supplement to 3.8 percent (P = 0.02), with a concomitant decrease of arachidonic acid, from 13.8 percent before the supplement to 8.6 percent (P = 0.04). Ten weeks after the end of supplemen tation, there was still a trend to increased eicosa- Decreased from presupplement levels (P<0.03). pentaenoic acid and decreased arachidonic acid concentrations, and the ratio of arachidonic acid to eicosapentaenoic acid remained significantly sup pressed at a value of 12.0, as compared with 20.9 before supplementation (P = 0.02) and 23.9 at week 20 after cessation of the supplement. Twenty weeks after the end ol' supplementation, both eicosapentae noic acid and arachidonic acid had returned to the presupplementation levels. Fig. I ). Ten weeks after the end of n -3 supplementation, lL-l/3 production had decreased further, to 2.9 ng per millili ter (61 percent decrease; P = 0.005).
Effect of n -3 Fatty Acid Supplementation on the Production of lnterleukin-1 and Tumor Necrosis Factor
The production of IL-1/3 returned to the presupple mentation level 20 weeks after the end of supplemen-268 THE NEW ENGLAND JOURNAL OF MEDICINE Feb. 2, 1989 tation (7.5 ng per milliliter; P not significant). During an interval of six weeks, IL-1 (3 production in a control group of four subjects (who were not taking the sup plement) did not change significantly (Fig. 1, inset) . Figure 2 shows the mean values for each subject, ex pressed as the percent change from values before sup plementation. Induction of IL-1 ¡3 by a higher dose of endotoxin (10 ng per milliliter) produced similar re sults (data not shown).
Endotoxin-induced concentrations of IL-1 a and tu mor necrosis factor decreased in a similar pattern ( Fig.  2A) . IL-1 a production fell from 16.0 ng per milliliter at base line to 10.9 ng per milliliter (32 percent de crease; P not significant) after 6 weeks of n -3 supple mentation, and to 9.7 ng per milliliter (39 percent decrease; P = 0.022) 10 weeks after the end of supple mentation. The production of tumor necrosis factor dropped from 8.5 ng per milliliter at base line to 6. per milliliter (22 percent decrease; P not significant) after 6 weeks of the supplement and to 5.1 ng per milliliter (40 percent decrease; P = 0.008) 10 weeks after the end of supplementation. Twenty weeks after the end of supplementation, the production of these cytokines had also returned to the presupplementation levels.
The proportion of monocytes in the mononuclear cell population (after Ficoll-Hypacjue separation) was 19.1 ±4.4 percent and did not change significantly after 6 weeks of the supplement or at 10 weeks after the end of supplementation.
The levels of interleukin-1 and tumor necrosis fac tor induced by the phagocytosis of heat-killed S. epi dermidis were measured ( Table 2 ). This phagocytic stimulus was four times more potent than the high dose of endotoxin (10 ng per milliliter) in inducing the production of I L -1 ¡3 and tumor necrosis factor. These levels showed slight, insignificant decreases during week 6 of the n -3 supplement and at 10 weeks after the end of supplementation.
To assess the possible role of altered interleukin-1 production in mediating the eilect of n -3 fatty acids during an immunologic challenge, we also measured the induction of IL-1 ¡3 and IL-1 a by phytohemagglu tinin in the same cell population (Fig. 2B ). After six weeks of n -3 supplementation, the production of IL-1 a had decreased significantly, from 14.0 to 12.0 ng per milliliter (14 percent decrease; P = 0.044). During the 10th week after the end of supplementa tion, however, both cytokines were significantly re duced: I L -1 (3 by 53 percent (from 3.0 to 1.4 ng per milliliter; P = 0.003), and IL-1 a by 37 percent (from 14.2 to 9.0 ng per milliliter; P = 0.0001).
We studied a control group during the same interval that we studied the second group of volunteers in the first two phases of n -3 supplementation. Although endotoxin stimulation of the mononuclear cells from these control subjects produced lower amounts ol IL-1/3 (Fig. 1, inset) , the production of this cytokine at week 7 did not significantly change (102±16 percent of the levels produced at week 1). The levels ol IL -la and tumor necrosis factor were 116± 10 and 90±6 percent, respectively, at week 7. At that time, cytokine production induced by S. epidennidis was 110± 8 percent of the levels at week 1 for IL-1/3, 100± 13 percent for I L -1 a, and 1 11 ± 2 percent for tu-Vol. 320 No. 5 THE NEW ENGLAND JOURNAL OF MEDICINE 269 mor necrosis factor. 'There was no significant change in the in vitro production of interleukin-1 and tumor necrosis factor in volunteers receiving no dietary sup plementation during an interval of six weeks.
Prostaglandin Synthesis
In the initial group of six volunteers, prostaglandin E-2 release was measured in the supernatant of mono nuclear cells stimulated by .S ', epidennidis (Fig. 3) . Pros taglandin E-j release decreased from 612 pg per millili ter at base line to 302 pg per milliliter after 6 weeks of supplementation (51 percent decrease; P = 0.008), to 423 pg per milliliter (P not significant) after 10 weeks of supplementation, and to 812 pg per milliliter (P not significant) after 20 weeks of supplementation. After cessation of the supplement there was no significant change in prostaglandin E 2 release from the presup plement level.
Neutrophil Chemotaxis
Random migration of polymorphonuclear neutro phils in both the study and control subjects was un changed at all times (data not shown). The chemotac-(ic responses of polymorphonuclear neutrophils after six weeks of n -3 supplementation were suppressed at all four concentrations of leukotriene B4. Figure 4 shows that chemotaxis to 10-/ M leukotriene B.(, which elicited the highest response, was 83±8.2 per cent (mean of percent increase over random migra tion) before the n -3 supplement, 62±5.0 percent after 6 weeks of the supplement, and 79 12.5 percent 10 weeks after cessation of the supplement. The suppres sion of chemotaxis after six weeks of supplementation was significant as compared with the presupplement control (P = 0.038) and with the control group as sayed on the same day (94± 1 1.9 percent; P = 0.041). 1'his is in agreement with the findings of Lee et al.10 on decreased neutrophil chemotaxis in healthy vol unteers whose diet was supplemented with n -3 fatty acids. D i s c u s s i o n O u r results show that dietary supplementation with n-3 fatty acids reduces the amount of inducible pro duction of interleukin-1 and tumor necrosis factor bv mononuclear cells in vitro. The reduced production of IL-1/3, IL-lct, and tumor necrosis factor may contrib ute to the decreased inflammatory responses reported in patients receiving n -3 supplem entation.Ŵ e studied the production of interleukin-1 and tumor necrosis factor bv total mononuclear cells rath-J n than by enriched monocytes. Since monocytes, I cells,32 B cells,33 and large granular lymphocytes34 synthesize interleukin-1 and tumor necrosis factor, we believe that the.response of the whole cell popula tion is biologically more relevant than that of en riched subpopulations. Although we studied periph eral mononuclear cells as an accessible source, it is probable that dietary n -3 fatty acids also decrease the production of interleukin-1 and tumor necrosis factor by other types of cells, such as synovial cells, alveolar macrophages, and mesangial,35 vascular,36 and skin cells.37 Since we measured total interleukin-1 and tu mor necrosis factor (i.e., both cell-associated and se creted), our results demonstrate that n -3 fatty acids affect the synthesis rather than the release of these J cytokines.
#
The persistent suppression of the production of interleukin-1 and tumor necrosis factor by mononucle- 4 ar cells for as long as 10 weeks after cessation of the n -3 supplement, accompanied by persistent fatty acid changes in these cells, was a striking phenomenon observed in both sets of volunteers. Since mono cytes in the circulation had been formed in the bone 4 marrow only a few days earlier,it is possible that our findings reflect the recycling of n -3 fatty acids from a slow-turnover compartment of fatty acids. The ratio of arachidonic acid to eicosapentaenoic acid, which was maximally suppressed immediately after n -3 supplementation, reflects the measurement of the total phospholipid fatty acid pool. This does not allow conclusions about intracellular compartments or phospholipid subclasses. Thus, we cannot exclude the altered fatty acid composition of a critical com partment at 10 weeks after the end of supplementa tion, when the suppression of cytokine production was maximal.
We observed functional changes in cytokine pro duction as late as 10 weeks after n -3 supplementation was discontinued; other investigators have also ob served the lo n g persistence of biochemical changes associated with n -3 fatty acid supplementation. 30 In a clinical trial in patients with rheumatoid arthritis,18 leukotriene B4 generation in neutrophils remained be low base-line levels for as Ion«' as 18 weeks after n -3 O fatty acid supplementation was stopped. Concom i tantly, in the crossover design of that study, the treat ment group still had clinical improvement when it entered the placebo phase after a washout period of four weeks. The prolonged effects of dietary n -3 fatty acid supplementation on the production of interleu kin-1 and tumor necrosis factor has implications for the design of future clinical trials. A maximal efiect on mononuclear-cell cytokine production may be reached slowly during supplementation and may persist for at least 10 weeks after cessation of the supplement. This prolonged effcct should be taken into account in the planning of washout periods, particularly in crossover designs.
The mechanism underlying the suppression of the synthesis of interleukin-1 and tumor necrosis factor after dietary supplementation with n -3 fatty acids remains unknown. However, alterations in the type of arachidonic acid metabolites produced during stimu lation of the mononuclear cells may explain in part the decreased production of these two cytokines.39,40 The n -3 fatty acids induce changes in both cyclooxygenase and lipoxygenase products. One possible mecha nism may be decreased 5-lipoxygenase metabolites such as leukotriene B .j.ln' ll> A dding exogenous leu kotriene B.j to hum an mononuclear cells enhances endotoxin-stimulated production of interleukin-1.11 Conversely, inhibitors of 5-lipoxygenase reduce the production of interleukin-1.42> 4:i Supplem entation with the same n -3 fatty acid preparation in the same dosage and during the same time as in the present study decreased monocyte leukotriene B.} production by 58 percent in healthy volunteers.lf{ Thus, a possible mechanism for decreased interleukin-1 production is decreased synthesis of leukotriene B.j and generation of the biologically less active metabolite leukotriene B5 from eicosapentaenoic acid.
Although the clinical importance of our observa tions is uncertain, our findings may explain in part the antiinflammatory ell'ects of n -3 fatty acids.18-21 Whether other unsaturated fatty acids have similar J effects remains to be determined.
